1. HBW Insight
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

Starpharma Pauses UK Sales Of COVID Nasal Spray

 
• By David Ridley

Starphama has paused sales of its antiviral COVID-19 nasal spray following correspondence with the UK medicines regulator “in relation to specific promotional claims made for Viraleze, including references to SARS-CoV-2 and COVID-19, and the interrelationship between these product claims and its categorization,” according to the firm.

3D_Coronavirus
• Source: Shutterstock

Australia’s Starpharma has paused UK sales of its Viraleze antiviral COVID-19 nasal spray following an intervention by the country’s medicines regulator, the MHRA.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe